A Form 4 filed with the SEC on August 21, 2026, discloses that Emily Rollins, a director of Xometry, Inc. (NASDAQ:XMTR), exercised a stock option and sold a total of 5,000 shares of Class A Common Stock on August 19, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Rollins exercised a fully vested stock option for 5,000 shares of Class A Common Stock at an exercise price of $12.32 per share on August 19, 2026.
  • Shares sold in three tranches: 2,540 shares at a weighted average price of $83.6073, 1,692 shares at a weighted average price of $84.827, and 768 shares at a weighted average price of $85.4666.
  • Price ranges: Sale prices ranged from $83.155 to $84.125, $84.17 to $85.17, and $85.22 to $86.07 across the three tranches, respectively.
  • Remaining ownership: Following all reported transactions, Rollins directly beneficially owned 15,136 shares of Class A Common Stock.
  • Derivative securities: Rollins holds 41,650 stock options (right to buy) with an exercise price of $12.32 and an expiration date of February 24, 2031.
  • 10b5-1 plan: According to the filing, all transactions were "effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."

Details of Rollins' Option Exercise and Share Sales at Xometry

According to the Form 4 filed by Kristie Scott as attorney-in-fact for Emily Rollins on August 21, 2026, Rollins acquired 5,000 shares of Class A Common Stock through the exercise of a fully vested stock option priced at $12.32 per share, bringing her direct beneficial ownership to 20,136 shares before the sales. The option, listed in Table II, carries an expiration date of February 24, 2031, and 41,650 such options remain directly held following the transaction.

The filing reports that Rollins then disposed of all 5,000 acquired shares across three separate sale transactions on the same date, August 19, 2026. The first tranche covered 2,540 shares at a weighted average price of $83.6073, with individual transaction prices ranging from $83.155 to $84.125. The second tranche involved 1,692 shares at a weighted average price of $84.827, with prices ranging from $84.17 to $85.17. The third tranche consisted of 768 shares at a weighted average price of $85.4666, with prices ranging from $85.22 to $86.07. The filing notes that full details of the number of shares sold at each separate price are available upon request to Xometry, any security holder, or SEC staff.

After all reported transactions, Rollins directly held 15,136 shares of Class A Common Stock, according to the filing. The filing indicates that Rollins is a director of Xometry, Inc. and that all transactions were carried out under a pre-established Rule 10b5-1 trading plan adopted at least 90 days before the trading date.

What Was Disclosed

The Form 4 discloses that Xometry director Emily Rollins exercised 5,000 stock options at $12.32 per share and sold the resulting shares on August 19, 2026, under a Rule 10b5-1 plan, leaving her with direct beneficial ownership of 15,136 shares of Class A Common Stock.